REMICADE (infliximab) for Rheumatoid Arthritis

Links shared publicly online about this topic.

  • 1,220
    total visits

REMICADE (infliximab) for Rheumatoid Arthritis

remicade.com

REMICADE" (infliximab) is a biologic treatment that can help induce remission of RA and relieve rheumatoid arthritis symptoms.

View full resource at remicade.com

Tags: Crohn's Disease Medication, Ulcerative Colitis Medication, Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Remicade

  • Share

Most Recently Shared on April 23, 2010 at 3:42 am By:

SusanS_Health Susan Scroggins

Learn how using Remicade can change the course of your rheumatoid arthritis. http://bit.ly/91P7AU

2 years ago...

Journal of Medical Case Reports | Abstract | Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report

jmedicalcasereports.com — “We present a rare case of Streptococcus pneumoniae polyarticular septic arthritis in a patient with rheumatoid arthritis receiving a single infusion of infliximab.View full resource at jmedicalcasereports.com

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 11:50 am By:

DerekDowell Derek Dowell Patient Expert

Abstract | Pneumococcal polyarticular septic arthritis after a single ... http://t.co/hcAk7wzA

3 months ago...

EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC

news-medical.net — “MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on January 21, 2012 at 9:30 am By:

Arthritis_News News-Medical.Net Health News

Arthritis News: EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC: MSD today anno... http://t.co/qMuhwKHJ

4 months ago...

Rheumatoid Arthritis Drugs May Increase Skin Cancer Risk

emaxhealth.com — “Use of rheumatoid arthritis drugs known as tumor necrosis factor (TNF) inhibitors (e.g., Enbrel, Remicade, others), may increase the risk of skin canc...View full resource at emaxhealth.com

  • View Related
  • Share

Most Recently Shared on September 9, 2011 at 5:42 pm By:

healthycarolina Denise Reynolds RD Nutritionist and Dietitian

Rheumatoid Arthritis Drugs May Increase Skin Cancer Risk http://t.co/xkypDcQ

9 months ago...

New report on the immunomodulators market outlook to 2016

news-medical.net — “TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 23, 2011 at 10:39 am By:

Arthritis_News News-Medical.Net Health News

Arthritis News: New report on the immunomodulators market outlook to 2016: TNF inhibitors indicated for the trea... http://t.co/1Xp7voQ

9 months ago...

TNF Inhibitors Double Infection Risk - General Medicine

general-medicine.jwatch.org — “Tumor necrosis factor- (TNF) inhibitors raise risk for infection in patients with rheumatoid arthritis. To quantitate this risk, Japanese investigators compared outcomes in 646 patients who were treated with TNF inhibitors (etanercept [Enbrel] or infliximab . . .View full resource at general-medicine.jwatch.org

  • View Related
  • Share

Most Recently Shared on July 29, 2011 at 3:49 pm By:

kussin49 Dr. Steven Z. Kussin Doctor, Internist, Gastroenterologist, and Physician

For patients with early rheumatoid arthritis these medications favorably change the course of the disease. They... http://fb.me/DXLPICd3

10 months ago...

Discontinuing Infliximab Can Benefit Early Rheumatoid Arthritis Patients : Internal Medicine News

internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice treView full resource at internalmedicinenews.com

  • View Related
  • Share

Most Recently Shared on July 14, 2011 at 8:47 pm By:

MedicalNewsNet Bob Finn - Medical News Net Health News

80% of patients w early rheumatoid arthritis can discontinue infliximab for at least 1 year with no ill effects. http://bit.ly/ooWWR1

11 months ago...

Rheumatology Article | Arthritis, Rheumatoid

mdlinx.com — “Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective studyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 8, 2011 at 8:30 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etan... http://bit.ly/qxfXnA #Rheumatology

11 months ago...

Family Medicine Article | Arthritis, Rheumatoid

mdlinx.com — “Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective studyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 7, 2011 at 6:04 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Which subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etane... http://bit.ly/prhAw8 #FamPractice

11 months ago...

Rheumatology Article | Arthritis, Rheumatoid

mdlinx.com — “Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt studyView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 6, 2011 at 5:55 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Discontinuation of infliximab and potential predictors of persistent low disease activity in patie... http://bit.ly/l8zytk #Rheumatology

1 year ago...

Rheumatology Article | Arthritis, Rheumatoid

mdlinx.com — “Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic characterization and assessment of switching to tocilizumabView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 5, 2011 at 5:43 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Primary lack of efficacy of infliximab therapy for rheumatoid arthritis: pharmacokinetic character... http://bit.ly/mnOAfI #Rheumatology

1 year ago...

Rheumatology Article | Arthritis, Rheumatoid

mdlinx.com — “Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of infliximab therapy in patients with rheumatoid arthritisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 22, 2011 at 9:17 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Baseline tumour necrosis factor alpha levels predict the necessity for dose escalation of inflixim... http://bit.ly/eK3tyb #Rheumatology

1 year ago...

Medical News: BSR: Infliximab May Help in Resistant Arthritis - in Meeting Coverage, BSR from MedPage Today

medpagetoday.com — “BRIGHTON, England -- Infliximab (Remicade) remains an option for patients with longstanding rheumatoid arthritis who have not responded adequately to another tumor necrosis factor (TNF) inhibitor, resView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on April 15, 2011 at 1:11 pm By:

MedicalNews Medical News Health News

BSR: Infliximab May Help in Resistant Arthritis (CME/CE) http://bit.ly/fF0X61

1 year ago...

Remicade | Drug safety information | Monitoring several patients | MediGuard

mediguard.org — “Remicade | Drug safety information | Monitoring several patients | MediGuardView full resource at mediguard.org

  • View Related
  • Share

Most Recently Shared on March 12, 2011 at 10:17 pm By:

Related Medications - Medbroadcast

medbroadcast.com — “Top 5 adalimumab (Humira®) etanercept (Enbrel®) ibuprofen (Advil®, Motrin®, generics) infliximab (Remicade®) methylprednisolone acetate (Depo-Medrol®, generics) Others methotrexate (Methotrexate®, generics) naproxen (Naprosyn®, generics) prednisone (generics) sodium aurothiomalate ...View full resource at medbroadcast.com

  • View Related
  • Share

Most Recently Shared on December 6, 2010 at 3:37 pm By:

MedBroadcast MedBroadcast Health News

Get the facts on 16 common drugs used to treat psoriatic arthritis, including information about potential side... http://fb.me/NQ81IPlX

1 year ago...

Rheumatology Article | Body Mass Index Arthritis, Rheumatoid

mdlinx.com — “Body mass index and clinical response to infliximab in rheumatoid arthritisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on November 10, 2010 at 9:04 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Body mass index and clinical response to infliximab in rheumatoid arthritis: Arthritis & Rheumatism http://bit.ly/cSDdHw #Rheumatology

2 years ago...

Advertisement